These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 913031)
1. Obesity and fasting--effects on drug metabolism and drug action in man. Reidenberg MM Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 2):729-34. PubMed ID: 913031 [No Abstract] [Full Text] [Related]
2. Unaltered metabolism of antipyrine and tolbutamide in fasting man. Reidenberg MM; Vesell ES Clin Pharmacol Ther; 1975 Jun; 17(6):650-6. PubMed ID: 1139856 [TBL] [Abstract][Full Text] [Related]
5. Quantitative change in metabolic fate of drug related to serum protein binding. Levy G J Pharm Sci; 1980 Jun; 69(6):746-7. PubMed ID: 7205605 [No Abstract] [Full Text] [Related]
6. Drug metabolism in uremia. Reidenberg MM Clin Nephrol; 1975; 4(3):83-5. PubMed ID: 1102176 [No Abstract] [Full Text] [Related]
7. [Induction of drug-catabolizing enzymes in chronic alcoholics]. Gundert-Remy U; Marquardt R; Andritsch F; Weber E Arch Biochem Biophys; 1974 Jan; 160(1):907-8. PubMed ID: 4828518 [No Abstract] [Full Text] [Related]
9. Influence of diabetes mellitus on drug metabolism in man. Daintith H; Stevenson IH; O'Malley K Int J Clin Pharmacol Biopharm; 1976 Jan; 13(1):55-8. PubMed ID: 1248919 [TBL] [Abstract][Full Text] [Related]
10. Effect of alphamethyldopa on the half-lives of antipyrine, tolbutamide and D-glucaric acid excretion in man. Gachályi B; Tornyossy M; Vas A; Káldor A Int J Clin Pharmacol Ther Toxicol; 1980 Mar; 18(3):133-5. PubMed ID: 6103880 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic consequences of aging. Richey DP; Bender AD Annu Rev Pharmacol Toxicol; 1977; 17():49-65. PubMed ID: 326170 [No Abstract] [Full Text] [Related]
12. Apparent volumes of distribution and drug binding to plasma proteins and tissues. Gibaldi M; McNamara PJ Eur J Clin Pharmacol; 1978 Jul; 13(5):373-80. PubMed ID: 668796 [TBL] [Abstract][Full Text] [Related]
13. Specifity and sensitivity of the inhibition of drug metabolism following inhalation of carbon disulphide-air mixtures. Freundt KJ; Kuttner P; Dreher W Arzneimittelforschung; 1976; 26(5):793-9. PubMed ID: 989352 [TBL] [Abstract][Full Text] [Related]
14. Brain uptake of metabolites and drugs following carotid arterial injections. Oldendorf WH Trans Am Neurol Assoc; 1971; 96():46-50. PubMed ID: 4400654 [No Abstract] [Full Text] [Related]
15. Studies on the different metabolic pathways of antipyrine as a tool in the assessment of the activity of different drug metabolizing enzyme systems in man [proceedings]. Van Boxtel CJ; Breimer DD; Danhof M Br J Pharmacol; 1980 Jan; 68(1):121P. PubMed ID: 7357141 [No Abstract] [Full Text] [Related]
16. Metabolism of drugs and carcinogens in man: antipyrine elimination as an indicator. Kalamegham R; Krishnaswamy K; Krishnamurthy S; Bhargava RN Clin Pharmacol Ther; 1979 Jan; 25(1):67-73. PubMed ID: 31258 [TBL] [Abstract][Full Text] [Related]
17. A simple flow injection analysis for studies of drug-protein binding interactions in serum. Gizurarson S; Jensen A; Foss S Acta Pharm Nord; 1989; 1(5):291-4. PubMed ID: 2610905 [TBL] [Abstract][Full Text] [Related]
18. Alterations in drug distribution and clearance due to obesity. Abernethy DR; Greenblatt DJ; Divoll M; Harmatz JS; Shader RI J Pharmacol Exp Ther; 1981 Jun; 217(3):681-5. PubMed ID: 7229998 [No Abstract] [Full Text] [Related]
19. [Drug metabolism in liver diseases]. Paumgartner G Z Gastroenterol Verh; 1979; 16():42-7. PubMed ID: 95370 [No Abstract] [Full Text] [Related]
20. Regulation of drug metabolism in man by environmental factors. Alvares AP; Pantuck EJ; Anderson KE; Kappas A; Conney AH Drug Metab Rev; 1979; 9(2):185-205. PubMed ID: 385270 [No Abstract] [Full Text] [Related] [Next] [New Search]